PlainRecalls
FDA Drug Low Class III Terminated

Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-01

Reported: December 2, 2020 Initiated: October 23, 2020 #D-0108-2021

Product Description

Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-01

Reason for Recall

Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A

Details

Units Affected
7176 bottles
Distribution
USA Nationwide
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-01. Recalled by Heritage Pharmaceuticals Inc. Units affected: 7176 bottles.
Why was this product recalled?
Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A
Which agency issued this recall?
This recall was issued by the FDA Drug on December 2, 2020. Severity: Low. Recall number: D-0108-2021.